1. Home
  2. COLL vs CASH Comparison

COLL vs CASH Comparison

Compare COLL & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$86.28

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLL
CASH
Founded
2002
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
COLL
CASH
Price
$45.38
$86.28
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$51.17
$91.00
AVG Volume (30 Days)
512.5K
231.7K
Earning Date
02-26-2026
01-22-2026
Dividend Yield
N/A
0.23%
EPS Growth
N/A
26.63
EPS
1.63
8.26
Revenue
$757,067,000.00
$786,023,000.00
Revenue This Year
$26.17
$10.95
Revenue Next Year
$3.65
$4.75
P/E Ratio
$28.19
$10.34
Revenue Growth
26.34
10.54
52 Week Low
$23.23
$64.45
52 Week High
$50.79
$86.92

Technical Indicators

Market Signals
Indicator
COLL
CASH
Relative Strength Index (RSI) 44.14 75.55
Support Level $44.43 $73.73
Resistance Level $48.29 $86.92
Average True Range (ATR) 2.15 2.09
MACD -0.25 1.30
Stochastic Oscillator 31.27 95.62

Price Performance

Historical Comparison
COLL
CASH

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: